MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craviso, G. L.
Right arrow Articles by Musacchio, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craviso, G. L.
Right arrow Articles by Musacchio, J. M.

High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization

GL Craviso and JM Musacchio

Tritiated dextromethorphan ([3H]DM) binds to two distinct sites in guinea pig brain, a high-affinity site (Kd = 13-20 nM) and a low- affinity site (Kd greater than 200 nM). Binding of [3H] DM to the high- affinity site is rapid, reversible, saturable, proportional to tissue concentration, and pH-dependent. The sites have a protein-like component, since preincubating brain homogenate in the presence of proteolytic enzymes and protein-modifying reagents significantly reduces binding. There is also a progressive loss of binding when brain homogenate is heated to temperatures in excess of 37 degrees. Millimolar concentrations of lithium, calcium, magnesium, and manganese decrease DM binding while sodium, in concentrations as high as 100 mM, has little effect; calcium in micromolar concentrations slightly enhances binding. The pons-medulla and cerebellum contain the highest density of sites. Subcellular localization studies have shown that high- affinity sites are confined almost exclusively to the microsomal fraction. Binding of DM to brain microsomes does not appear to be related to drug-metabolizing enzymes. The characteristics of DM binding suggest that DM sites are not a subclass of opiate receptors. Studies using tritiated dextrorphan as radioligand failed to reveal a high- affinity binding site for in brain.

Volume 23, Issue 3, pp. 619-628, 05/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Liu, L. Qin, G. Li, W. Zhang, L. An, B. Liu, and J.-S. Hong
Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 212 - 218.
[Abstract] [Full Text]

Home page
 Anesth. Analg.Home page
A. A. Weinbroum
Dextromethorphan Reduces Immediate and Late Postoperative Analgesic Requirements and Improves Patients' Subjective Scorings After Epidural Lidocaine and General Anesthesia
Anesth. Analg., June 1, 2002; 94(6): 1547 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Snyder
Drug and neurotransmitter receptors in the brain
Science, April 6, 1984; 224(4644): 22 - 31.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics